The expression of GRM8, SPC25, and FAM72A was negatively correlated with favorable outcomes and also observed in other cancer types such as lung cancer (Zhang et al., 2019; Chen et al., 2018) and breast cancer (Wang et al., 2019). Here, SPC25 is linked to breast cancer.